• Contact Us
  • Databases
Crown Bioscience Logo - An expert pre-clinical CRO
  • Services
    • Therapeutic Areas
    • Model Systems
    • Technologies
    • Service Type
  • About Us
    • Our Company
    • Our Purpose
    • Our Responsibility
    • Leadership Team
    • News & Events
    • Careers
  • Our Science
    • Publications
    • Resources
    • Blog
  • Blog

CDX models

When to Use Conventional Cell Line Derived Xenograft Models

2 minute read

When to Use Conventional Cell Line Derived Xenograft Models

May 23, 2017

Search our Blog

Categories

  • ADCs
  • Alzheimer's
  • Biomarkers
  • Bladder Cancer
  • Blood Cancer
  • Breast Cancer
  • Cancer Stem Cells
  • CDX models
  • Cell Lines
  • Clinical Trials
  • Colorectal Cancer
  • Diabetes
  • Diagnostics
  • DNA Damage Response
  • Esophageal Cancer
  • GEMM Models
  • Glioblastoma
  • IBD
  • Imaging
  • Immuno-oncology
  • Inflammation
  • Liver Cancer
  • Lupus
  • Metastasis
  • MS
  • NGS
  • Head and Neck Cancer
  • Obesity
  • Oncogenes
  • Oncolytic Viruses
  • Organoids
  • Ovarian Cancer
  • Pancreatic Cancer
  • PARP inhibitors
  • PDX Models
  • PDXO Models
  • Pediatric Cancer
  • RAS proteins
  • Sequencing
  • Skin Cancer
  • Stomach Cancer
  • Syngeneic Models
  • Tumor Homograft

About Us

  • Our Company
  • Our Purpose
  • Our Responsibility
  • Leadership
  • News & Events

Our Services

  • Therapeutic Areas
  • Model Systems
  • Technologies
  • Service Type

Resources

  • Blog
  • Publications
  • Factsheets
  • Application Notes
  • Webinars
  • Ebooks

Platforms

  • OncoExpress™
  • XenoBase™
  • MuBase™
  • HuBase™
  • OrganoidBase™

Talk To Us

  • sales@crownbio.com
  • +1 858 622 2900
  • Contact Us
  • LinkedIn
  • Twitter

Crown Bioscience

© 2023 Crown Bioscience. All Rights Reserved. 

Privacy Policy. Manage Privacy Preferences

A JSR Life Sciences Company

A JSR Life Sciences Company

  •  
  •  

© 2023 Crown Bioscience. All Rights Reserved. Privacy Policy